rs113155624

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_006567.5(FARS2):​c.102G>A​(p.Ser34Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00372 in 1,614,138 control chromosomes in the GnomAD database, including 141 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0091 ( 20 hom., cov: 32)
Exomes 𝑓: 0.0032 ( 121 hom. )

Consequence

FARS2
NM_006567.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -3.79

Publications

2 publications found
Variant links:
Genes affected
FARS2 (HGNC:21062): (phenylalanyl-tRNA synthetase 2, mitochondrial) This gene encodes a protein that transfers phenylalanine to its cognate tRNA. This protein localizes to the mitochondrion and plays a role in mitochondrial protein translation. Mutations in this gene can cause combined oxidative phosphorylation deficiency 14 (Alpers encephalopathy). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
FARS2 Gene-Disease associations (from GenCC):
  • metabolic disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • combined oxidative phosphorylation defect type 14
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hereditary spastic paraplegia 77
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 6-5368672-G-A is Benign according to our data. Variant chr6-5368672-G-A is described in ClinVar as Benign. ClinVar VariationId is 137288.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.79 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00912 (1389/152252) while in subpopulation SAS AF = 0.0434 (209/4812). AF 95% confidence interval is 0.0386. There are 20 homozygotes in GnomAd4. There are 728 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FARS2NM_006567.5 linkc.102G>A p.Ser34Ser synonymous_variant Exon 2 of 7 ENST00000274680.9 NP_006558.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FARS2ENST00000274680.9 linkc.102G>A p.Ser34Ser synonymous_variant Exon 2 of 7 1 NM_006567.5 ENSP00000274680.4
FARS2ENST00000324331.10 linkc.102G>A p.Ser34Ser synonymous_variant Exon 2 of 7 1 ENSP00000316335.5
FARS2ENST00000602691.1 linkc.102G>A p.Ser34Ser synonymous_variant Exon 3 of 3 3 ENSP00000473394.1
FARS2ENST00000648580.1 linkn.102G>A non_coding_transcript_exon_variant Exon 2 of 9 ENSP00000497889.1

Frequencies

GnomAD3 genomes
AF:
0.00912
AC:
1387
AN:
152134
Hom.:
20
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0266
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00321
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0436
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00671
GnomAD2 exomes
AF:
0.00679
AC:
1703
AN:
250940
AF XY:
0.00783
show subpopulations
Gnomad AFR exome
AF:
0.0278
Gnomad AMR exome
AF:
0.00153
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000115
Gnomad OTH exome
AF:
0.00392
GnomAD4 exome
AF:
0.00316
AC:
4613
AN:
1461886
Hom.:
121
Cov.:
32
AF XY:
0.00410
AC XY:
2983
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.0284
AC:
951
AN:
33480
American (AMR)
AF:
0.00179
AC:
80
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.0366
AC:
3155
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00537
AC:
31
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000971
AC:
108
AN:
1112008
Other (OTH)
AF:
0.00469
AC:
283
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
328
655
983
1310
1638
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00912
AC:
1389
AN:
152252
Hom.:
20
Cov.:
32
AF XY:
0.00978
AC XY:
728
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.0266
AC:
1103
AN:
41540
American (AMR)
AF:
0.00320
AC:
49
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.0434
AC:
209
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68014
Other (OTH)
AF:
0.00664
AC:
14
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
65
130
196
261
326
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00434
Hom.:
5
Bravo
AF:
0.00975
Asia WGS
AF:
0.0160
AC:
57
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 19, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Combined oxidative phosphorylation defect type 14 Benign:2
Jun 13, 2018
Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.092
DANN
Benign
0.35
PhyloP100
-3.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113155624; hg19: chr6-5368905; API